Emergencies in the Cancer Patient 2024 — On Demand

Friday, January 10, 2025, 8:15 AM - Saturday, May 31, 2025, 11:00 PM

Oncologic emergencies rapidly evolved in medicine over the last 10-15 years, developing in parallel with advancing cancer treatments and interventions. In addition to treating complications related to standard/traditional chemotherapies, the emergence of numerous new cancer treatment modalities has introduced a whole new field of patient complaints that have only recently begun to appear in emergency departments across the country. With very few dedicated cancer hospital emergency rooms, patients presenting with cancer emergencies were often inappropriately triaged, diagnosed, undertreated, or simply referred back to their respective oncologists without resolution of their emergent issues.

This on-demand program, originally recorded live on December 14–15, 2024, features experts from across the cancer treatment spectrum to provide emergency department providers and staff with the knowledge and skills needed to manage both common and uncommon cancer-related emergencies, including:

— Infections and Sepsis
— Pain Control and Palliation
— Interventional Emergencies
— Stem Cell Transplant / Targeted Therapy / Experimental Therapeutics Complications and Side Effects
— CNS Emergencies
— Radiation Treatments and Complications
— Hypercoagulation and Thrombosis, Dermatologic Side Effects, and Malignant Hypercalcemia

Each lecture concludes with a recorded Q&A with the faculty. For more information, including a detailed list of presentations, view the brochure from the live course.

This program is intended for physicians, nurse practitioners, physician assistants, and registered nurses involved in the treatment and management of patients with active malignancies/cancers who present with acute complaints in an emergency room setting.

1. Identify and recognize the most common presenting complaints of cancer patients in emergency rooms.
2. Discuss current and developing cancer therapeutics with respect to their side-effects and complications.
3. Recognize the current limitations and challenges that remain in efficiently addressing cancer patient emergencies.

Access to the course content requires registration. Once registered, all materials, including relevant financial disclosures and instructions for claiming credit, are located under the 'Course Content' tab. This on-demand program is available for purchase until May 31, 2025. For those that purchase this on demand, access to the content, as well as the opportunity to claim credit, is available through September 30, 2025.

On Demand Access Fees

— Physicians (MDs, PhDs, and DOs): $550
— Advanced Practice Providers: $450
— Nursing and Other Healthcare Professionals: $400
— Residents, Fellows, and Students: $200
— MSK Employees: Complimentary

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information and to submit a request. Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

This Memorial Sloan Kettering Continuing Medical Education on demand program is non-refundable.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material activity for a maximum of 15.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Recorded/Review Date: December 14-15, 2024 | Original Release Date: January 10, 2025 | Termination Date: September 30, 2025

MSK Conference Director

George K. Wang, MD, PhD
Associate Attending, Emergency Care Service,
Department of Medicine

 

MSK Conference Moderator 

Thomas John, MD
Assistant Attending, Emergency Care Service,
Department of Medicine

 

Invited Faculty 

Tim Cooksley, MD, FRCP
The Christie NHS Foundation Trust
Manchester, UK 

MSK Faculty 

Mark H. Bilsky, MD
William E. Snee Chair;
Vice Chairman of Clinical Affairs, Neurosurgery;
Chief, Multi-Disciplinary Spine Tumor Service; 
Attending, Department of Neurosurgery

Adrienne A. Boire, MD, PhD
Geoffrey Beene Junior Faculty Chair;
Associate Attending, 
Department of Neurology

Sanjay Chawla, MD, FCCP, FACP, FCCM
Attending, Critical Care Medicine Service, 
Department of Anesthesiology-Critical Care

Linda Chen, MD
Assistant Attending, 
Department of Radiation Oncology

Azeez Farooki, MD
Attending, Endocrinology Service,
Department of Medicine

Allison Gordon, MD
Assistant Attending, Dermatology Service,
Department of Medicine

Jeffrey S. Groeger, MD
Attending, Emergency Care Service,
Department of Medicine

Avi Leader, MD
Assistant Attending, Hematology Service,
Department of Medicine

Robert P. Lee, MD, FCCP, DAABIP
Section Head, Interventional Pulmonology;
Program Director, Interventional Pulmonology Fellowship;
Associate Attending, Pulmonary Service,
Department of Medicine

Aron Legler, MD, FASA
Assistant Attending, Anesthesiology Service,
Department of Anesthesiology-Critical Care

Peter A. Mead, MD
Assistant Attending, Infectious Diseases Service,
Department of Medicine

Mark Melrose, DO, FACEP
Associate Attending, Emergency Care Service,
Department of Medicine

Gilles Salles, MD, PhD
Chief, Lymphoma Service,
Steven A. Greenberg Chair,
Department of Medicine

Reggie Saldivar, MD, FCCP, FACP, FCCM
Associate Attending, Supportive Care,
Department of Medicine

Fernando C. Santini, MD
Assistant Attending, Thoracic Oncology Service,
Department of Medicine

Michael Scordo, MD
Assistant Attending, Bone Marrow Transplant Service,
Department of Medicine

Valeria Silva Merea, MD
Director, Speech and Hearing Center;
Assistant Attending, Head and Neck Service,
Department of Surgery

Iris H. Wei, MD, FACS
Assistant Attending, Colorectal Service,
Department of Surgery

Amy Xu, MD, PhD
Co-Director, Inpatient Radiation Oncology Consult (IROC) Service;
Assistant Attending, 
Department of Radiation Oncology

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.